James Mond
36Patents
12h-index
24Co-inventors
81Inventor score
Filing activity: Mar 8, 1995 → May 23, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5585100A | Dual carrier immunogenic construct | Emerging Cross-Sectional Technologies | 79 | Expired |
| US5955079A | Dual carrier immunogenic construct | Emerging Cross-Sectional Technologies | 75 | Expired |
| US6977245B2 | Oligodeoxynucleotide and its use to induce an immune response | Emerging Cross-Sectional Technologies | 57 | Expired |
| US6299881A | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts | Emerging Cross-Sectional Technologies | 37 | Expired |
| US6248334A | Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process | Emerging Cross-Sectional Technologies | 33 | Expired |
| US6432679B1 | Enhancement of B cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and EBV Gp350/220 | Chemistry; Metallurgy | 24 | Expired |
| US5874085A | Vaccine for enhanced production of IgA antibodies | Chemistry; Metallurgy | 23 | Expired |
| US7517852B2 | Compositions and methods for treating bacteria | Human Necessities | 17 | Active |
| US8030285B2 | Oligodeoxynucleotide and its use to induce an immune response | Emerging Cross-Sectional Technologies | 16 | Active |
| US7410647B2 | Antigenic polypeptides | Emerging Cross-Sectional Technologies | 14 | Expired |
| US9815886B2 | Compositions and methods for the treatment of immunodeficiency | Emerging Cross-Sectional Technologies | 13 | Active |
| US7960356B2 | Oligodeoxynucleotide and its use to induce an immune response | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7250494B2 | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria | Chemistry; Metallurgy | 11 | Expired |
| US9969793B2 | Compositions and methods for the treatment of immunodeficiency | Emerging Cross-Sectional Technologies | 9 | Active |
| US9714283B2 | Compositions and methods for the treatment of immunodeficiency | Emerging Cross-Sectional Technologies | 9 | Active |
| US7452533B2 | Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol | Human Necessities | 9 | Expired |
| US9107906B1 | Compositions and methods for the treatment of immunodeficiency | Emerging Cross-Sectional Technologies | 8 | Active |
| US7777017B2 | Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria | Chemistry; Metallurgy | 8 | Active |
| US6756041B2 | Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7166708B2 | Process for preparing conjugate vaccines and the conjugate vaccines | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8227446B2 | Oligodeoxynucleotide and its use to induce an immune response | Emerging Cross-Sectional Technologies | 5 | Active |
| US10683343B2 | Compositions and methods for the treatment of immunodeficiency | Emerging Cross-Sectional Technologies | 4 | Active |
| US7576054B2 | Compositions and methods for treating bacteria | Human Necessities | 2 | Active |
| US9962436B2 | Multimeric fusion protein vaccine and immunotherapeutic | Emerging Cross-Sectional Technologies | 2 | Active |
| US8389495B2 | Olioodeoxynucleotide and its use to induce an immune response | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.